Similar articles for PMID: 15538591

Year	Number of Results
1993	1
1994	2
1996	2
1997	2
1998	1
1999	4
2000	3
2001	6
2002	5
2003	3
2004	8
2005	10
2006	9
2007	8
2008	7
2009	2
2010	11
2011	11
2012	7
2013	10
2014	13
2015	12
2016	8
2017	9
2018	8
2019	8
2020	9
2021	2
2022	5
2024	0

1

Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up.

Kordon A, Kahl KG, Broocks A, Voderholzer U, Rasche-Räuchle H, Hohagen F. Kordon A, et al. Eur Arch Psychiatry Clin Neurosci. 2005 Feb;255(1):48-50. doi: 10.1007/s00406-004-0533-y. Epub 2004 Nov 12. Eur Arch Psychiatry Clin Neurosci. 2005. PMID: 15538591

2

Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.

Simpson HB, Gorfinkle KS, Liebowitz MR. Simpson HB, et al. J Clin Psychiatry. 1999 Sep;60(9):584-90. doi: 10.4088/jcp.v60n0904. J Clin Psychiatry. 1999. PMID: 10520976 Clinical Trial.

3

Efficacy of cognitive behavioural therapy with medication for patients with obsessive-compulsive disorder: A multicentre randomised controlled trial in China.

Meng FQ, Han HY, Luo J, Liu J, Liu ZR, Tang Y, Hou X, Wei J, Shi LL, Tang MN, Yan YP, Huang YQ, Sun J, Li ZJ. Meng FQ, et al. J Affect Disord. 2019 Jun 15;253:184-192. doi: 10.1016/j.jad.2019.04.090. Epub 2019 Apr 22. J Affect Disord. 2019. PMID: 31108379 Clinical Trial.

4

Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial.

Foa EB, Simpson HB, Gallagher T, Wheaton MG, Gershkovich M, Schmidt AB, Huppert JD, Imms P, Campeas RB, Cahill S, DiChiara C, Tsao SD, Puliafico A, Chazin D, Asnaani A, Moore K, Tyler J, Steinman SA, Sanches-LaCay A, Capaldi S, Snorrason Í, Turk-Karan E, Vermes D, Kalanthroff E, Pinto A, Hamlett GE, Middleton R, Hahn CG, Xu B, Van Meter PE, Katechis M, Rosenfield D. Foa EB, et al. JAMA Psychiatry. 2022 Mar 1;79(3):193-200. doi: 10.1001/jamapsychiatry.2021.3997. JAMA Psychiatry. 2022. PMID: 35080598 Free PMC article. Clinical Trial.

5

Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.

Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, Vallejo J. Alonso P, et al. J Clin Psychiatry. 2001 Jul;62(7):535-40. doi: 10.4088/jcp.v62n07a06. J Clin Psychiatry. 2001. PMID: 11488364 Clinical Trial.

6

A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.

Saxena S, Winograd A, Dunkin JJ, Maidment K, Rosen R, Vapnik T, Tarlow G, Bystritsky A. Saxena S, et al. J Clin Psychiatry. 2001 Jan;62(1):67-72; quiz 73. doi: 10.4088/jcp.v62n0114b. J Clin Psychiatry. 2001. PMID: 11235937 Clinical Trial.

7

Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.

Tundo A, Salvati L, Busto G, Di Spigno D, Falcini R. Tundo A, et al. J Clin Psychiatry. 2007 Oct;68(10):1552-6. doi: 10.4088/jcp.v68n1013. J Clin Psychiatry. 2007. PMID: 17960971

8

Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.

Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, McLean CP, Bender J Jr, Marcus SM, Williams MT, Weaver J, Vermes D, Van Meter PE, Rodriguez CI, Powers M, Pinto A, Imms P, Hahn CG, Campeas R. Simpson HB, et al. JAMA Psychiatry. 2013 Nov;70(11):1190-9. doi: 10.1001/jamapsychiatry.2013.1932. JAMA Psychiatry. 2013. PMID: 24026523 Free PMC article. Clinical Trial.

9

Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: a prospective 1-year follow-up study.

Anand N, Sudhir PM, Math SB, Thennarasu K, Janardhan Reddy YC. Anand N, et al. J Anxiety Disord. 2011 Oct;25(7):939-45. doi: 10.1016/j.janxdis.2011.05.007. Epub 2011 Jun 1. J Anxiety Disord. 2011. PMID: 21689902 Clinical Trial.

10

Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study.

Catapano F, Perris F, Masella M, Rossano F, Cigliano M, Magliano L, Maj M. Catapano F, et al. J Psychiatr Res. 2006 Sep;40(6):502-10. doi: 10.1016/j.jpsychires.2005.04.010. J Psychiatr Res. 2006. PMID: 16904424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

163 results

Results by year